ADTRALZA

Found in: Lithuania United Kingdom

Active ingredients

#
Active Ingredient
Description
1

Tralokinumab is a fully human IgG4 monoclonal antibody that specifically binds to the type 2 cytokine interleukin-13 (IL-13) and inhibits its interaction with the IL-13 receptors. IL-13 is a major driver of human type 2 inflammatory disease, such as atopic dermatitis and inhibiting the IL-13 pathway with tralokinumab in patients decreases many of the mediators of type 2 inflammation.

Medicine classification

ATC Code
Title
Class
Tralokinumab
D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AH Agents for dermatitis, excluding corticosteroids

Product monographs

Monograph
Type
Country

Identifiers

Authority
Identifier(s)
Medicines & Healthcare Products Regulatory Agency (GB)
Identifier(s): 399359
Valstybinė vaistų kontrolės tarnyba (LT)
Identifier(s): 1092843, 1092844, 1092845